Franke K, Kettering M, Lange K, Kaiser W, Hilger I. The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels. Int J Nanomedicine. 2013;8:351-63 pubmed publisher

Henderson M, Haber M, Porro A, Munoz M, Iraci N, Xue C, et al. ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux. J Natl Cancer Inst. 2011;103:1236-51 pubmed publisher

Wittgen H, van den Heuvel J, Van den Broek P, Dinter Heidorn H, Koenderink J, Russel F. Cannabinoid type 1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4. Drug Metab Dispos. 2011;39:1294-302 pubmed publisher

Porro A, Haber M, Diolaiti D, Iraci N, Henderson M, Gherardi S, et al. Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells. J Biol Chem. 2010;285:19532-43 pubmed publisher

Hoffmann K, Mehrle S, Schmidt J, Buchler M, Marten A. Interferon-alpha restitutes the chemosensitivity in pancreatic cancer. Anticancer Res. 2008;28:1499-507 pubmed